BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 34356877)

  • 1. Animal Models of Autosomal Recessive Parkinsonism.
    Bastioli G; Regoni M; Cazzaniga F; De Luca CMG; Bistaffa E; Zanetti L; Moda F; Valtorta F; Sassone J
    Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spiny Projection Neuron Dynamics in Toxin and Transgenic Models of Parkinson's Disease.
    Du Y; Graves SM
    Front Neural Circuits; 2019; 13():17. PubMed ID: 30930753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of DJ-1 in the pathogenesis of Parkinson's disease.
    Wang ZQ; Zhou HY; Chen SD
    Neurosci Bull; 2006 Jul; 22(4):232-4. PubMed ID: 17704838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspective of mitochondrial biology in Parkinson's disease.
    Ammal Kaidery N; Thomas B
    Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease.
    Yamashita H; Matsumoto M
    Regen Med; 2007 Jul; 2(4):447-55. PubMed ID: 17635051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifactorial sleep disturbance in Parkinson's disease.
    Albers JA; Chand P; Anch AM
    Sleep Med; 2017 Jul; 35():41-48. PubMed ID: 28619181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson's Disease.
    Kim J; Daadi EW; Oh T; Daadi ES; Daadi MM
    Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione
    Jewett M; Dickson E; Brolin K; Negrini M; Jimenez-Ferrer I; Swanberg M
    Front Neurol; 2018; 9():222. PubMed ID: 29681884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pesticides and Parkinson's disease.
    Sherer TB; Betarbet R; Greenamyre JT
    ScientificWorldJournal; 2001 May; 1():207-8. PubMed ID: 12805673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA Dysregulation in Parkinson's Disease: A Narrative Review.
    Nies YH; Mohamad Najib NH; Lim WL; Kamaruzzaman MA; Yahaya MF; Teoh SL
    Front Neurosci; 2021; 15():660379. PubMed ID: 33994934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Description of Parkinson's disease as a clinical syndrome.
    Fahn S
    Ann N Y Acad Sci; 2003 Jun; 991():1-14. PubMed ID: 12846969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxin models of mitochondrial dysfunction in Parkinson's disease.
    Martinez TN; Greenamyre JT
    Antioxid Redox Signal; 2012 May; 16(9):920-34. PubMed ID: 21554057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.
    Sarkar S; Raymick J; Imam S
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease: animal models and dopaminergic cell vulnerability.
    Blesa J; Przedborski S
    Front Neuroanat; 2014; 8():155. PubMed ID: 25565980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Drosophila model for parkinsonism by targeting phosphoglycerate kinase.
    Shimizu J; Kasai T; Yoshida H; Huynh AM; Nakao-Azuma Y; Shinomoto M; Tokuda T; Mizuno T; Yamaguchi M
    Neurochem Int; 2020 Oct; 139():104816. PubMed ID: 32758590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease.
    Deng I; Corrigan F; Zhai G; Zhou XF; Bobrovskaya L
    Brain Behav Immun Health; 2020 Apr; 4():100060. PubMed ID: 34589845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute dopamine receptor blockade in substantia nigra pars reticulata: a possible model for drug-induced Parkinsonism.
    Cáceres-Chávez VA; Hernández-Martínez R; Pérez-Ortega J; Herrera-Valdez MA; Aceves JJ; Galarraga E; Bargas J
    J Neurophysiol; 2018 Dec; 120(6):2922-2938. PubMed ID: 30256736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic mouse models of parkinsonism: strengths and limitations.
    Fleming SM; Fernagut PO; Chesselet MF
    NeuroRx; 2005 Jul; 2(3):495-503. PubMed ID: 16389313
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.